Stem cell therapy promising for rheumatoid arthritis – PMLiVE
|
Stem cell therapy promising for rheumatoid arthritis
PMLiVE Mesoblast Shares in Australian biotech Mesoblast have surged after the company reported encouraging results from a clinical trial of a stem cell-based therapy for patients with rheumatoid arthritis (RA). The data comes from the first cohort of a phase … |
